The latest cancer drugs news
Browsing: Cancer Drug News
FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukaemia
On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix,…
FDA approves zolbetuximab-clzb with chemotherapy for gastric or gastroesophageal junction adenocarcinoma
Tthe Food and Drug Administration have approved zolbetuximab-clzb, a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, with…
Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2…
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer
A new drug called WNTinib can delay the growth of tumours and improve survival in…
Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise…
Scientists discover chemical probes for previously “undruggable” cancer target
Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein…
Significant worldwide disparities in availability and timeliness of new cancer drugs
Despite considerable progress in the discovery and development of new cancer drugs, there are significant…
FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer
On October 3, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb…
Researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients
Patients with advanced HER2-positive breast cancer very often develop brain metastases. When this happens, patients…
Seeing double: Designing drugs that target “twin” cancer proteins
Some proteins in the human body are easy to block with a drug; they have…